(OCGN) – Business Wire
-
National Philanthropic Trust Welcomes Three Board Members
-
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing
-
Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
Back to OCGN Stock Lookup